Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in FTXH
24.0%
% of FTXH's 51 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.4% | 6.9% | 6.4% |
|
ABBVIE INC | 5.9% | 6.9% | 5.9% |
|
BRISTOL-MYERS SQUIBB CO | 5.7% | 8.7% | 5.7% |
|
MERCK & CO. INC. | 5.0% | 6.7% | 5.0% |
|
PFIZER INC | 4.3% | 6.8% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to FTXH
|
ELI LILLY & CO | 9.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 8.1% |
|
MCKESSON CORP | 5.6% |
|
AMERISOURCEBERGEN CORP | 4.9% |
 |
NOVARTIS AG-ADR | 4.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 3.9% |
 |
TEVA PHARMACEUTICAL-SP ADR | 3.6% |
PPH Underweight Relative to FTXH
|
GILEAD SCIENCES INC | -4.5% |
|
CARDINAL HEALTH INC | -4.1% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
AMGEN INC | -3.1% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
BIOGEN IDEC INC | -2.8% |
|
PFIZER INC | -2.6% |
|
CHARLES RIVER LABORATORIES | -2.4% |
|
REGENERON PHARMACEUTICALS | -2.4% |
 |
JAZZ PHARMACEUTICALS PLC | -2.4% |